Showing results (1-10 of 350) with videos related to
Sort By:
Pageof 35
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Humanized antibodies for antiviral therapyM S Co, M Deschamps, R J Whitley, et al.The Journal of Experimental Medicine|October 1, 1992
Engineered humanized dimeric forms of IgG are more effective antibodiesP C Caron, W Laird, M S Co, et al.Cancer Research|December 15, 1992
Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodiesP C Caron, M S Co, M K Bull, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
Chimeric and humanized antibodies with specificity for the CD33 antigenM S Co, N M Avdalovic, P C Caron, et al.Molecular Immunology|October 1, 1993
Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibodyM S Co, D A Scheinberg, N M Avdalovic, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injuryM Buerke, A S Weyrich, T Murohara, et al.Neurology|December 1, 1995
Sorivudine: a promising drug for the treatment of varicella-zoster virus infectionR J WhitleyThe Annals of Pharmacotherapy|September 1, 1996
The past as prelude to the future: history, status, and future of antiviral drugsR J WhitleyThe Journal of Antimicrobial Chemotherapy|May 1, 1996
Drug discovery for human immunodeficiency virus infection: conquests and hurdlesR J WhitleyPageof 35